Tuberculosis of the Central Nervous System


Tuberculosis in all its forms remains a challenging clinical problem and a public health issue of considerable magnitude. Each year there are an estimated 10 million new cases of active disease worldwide and 1.3 million deaths attributable to tuberculosis. In 2018, 9,029 new cases of active tuberculosis were reported in the United States, an incidence rate of 2.8 cases per 100,000 persons. Pulmonary tuberculosis accounts for 70 percent of active cases, isolated extrapulmonary disease 20 percent, and combined extrapulmonary and pulmonary disease 10 percent.

Tuberculosis of the central nervous system (CNS) accounts for approximately 1 to 2 percent of reported patients with active infection and 8 percent of all forms of extrapulmonary tuberculosis in immunocompetent individuals. While pulmonary tuberculosis in the United States has declined gradually in recent decades, the number of reported cases of meningeal tuberculosis has changed little and the case fatality rate remains high despite the availability of effective antituberculous therapy. CNS tuberculosis may be considered as comprising three clinical syndromes: meningitis, intracranial tuberculoma, and spinal tuberculous arachnoiditis. All three forms of CNS infection are encountered with near equal frequency in regions of the world where the incidence of tuberculosis is high. In Europe and North America, where the incidence is lower and extrapulmonary tuberculosis is seen primarily in adults with reactivation disease, the large majority of cases present with meningitis.

Meningitis

Pathogenesis

Current understanding of the pathogenesis of CNS tuberculosis is based on a series of careful clinicopathologic correlations that date to the early part of the last century. Conceptually, there is a two-phase process, beginning with the hematogenous dissemination of Mycobacterium tuberculosis (bacillemia) that follows primary pulmonary infection or late reactivation elsewhere in the body. During this hematogenous phase, small numbers of bacilli are scattered throughout the substance of the brain, meninges, and adjacent tissues, leading to the formation of multiple granulomatous foci of varying size and degree of encapsulation (tubercles). In the second phase, such lesions coalesce to form larger caseous foci, some of which may lie just beneath the pia mater (the thin vascular membrane consisting of blood vessels and lymphatics that covers the entire surface of the brain) or beneath the ependyma (the thin nucleated epithelial membrane that lines the surface of the ventricles). With time and circumstance, a subpial or subependymal tuberculoma may destabilize and erode into the subarachnoid space, producing meningitis ( Fig. 40-1 ). It follows that the propensity for developing clinical disease is determined by the number of tubercles and their proximity to the surface of the brain, the rapidity of progression, and the rate at which encapsulation follows acquired immunity.

Figure 40-1, Section from an autopsied case of tuberculous meningitis showing fresh granulomas beneath the surface of the brain, having eroded through the pia membrane into the subarachnoid space. (Hematoxylin and eosin, ×400.)

The widespread and dense distribution of tubercles that occurs in progressive miliary tuberculosis greatly increases the chance that a juxtapial granuloma will be established and, from this critical location, break through into the subarachnoid space. This is the usual sequence in childhood tuberculous meningitis, as infants and young children are especially susceptible to progressive hematogenous dissemination following primary infection. Adult cases also develop in association with the bacillemia of progressive miliary disease or other less apparent or entirely hidden foci of chronic organ tuberculosis. Secondary hematogenous dissemination may be intermittent or chronic and progressive. In either circumstance, the spread of bacilli to distant organs produces scattered tubercles of varying size and encapsulation. Subpial tuberculous foci arising in this manner may remain quiescent for months or years, then destabilize when local injury or a depression in host immunity supervenes. Risk factors include advanced age, alcoholism, drug-induced immunosuppression, lymphoma, and infection with human immunodeficiency virus (HIV), all of which impair cellular immunity and, in persons with smoldering chronic organ tuberculosis, can lead to generalized tuberculosis including meningitis.

A significant proportion of adult cases of tuberculous meningitis have no demonstrable extracranial infection or apparent defect in host immune function. Occasionally, there is a history of head trauma some weeks or months prior to the onset of symptoms, suggesting that intracranial caseous foci may be destabilized by physical factors.

Pathology

The pathologic changes observed in the CNS result from an intense, cytokine-mediated hypersensitivity reaction induced by the presence of organisms and associated antigenic material in the substance of the brain and subarachnoid space. Three features dominate the pathologic process and account for the clinical manifestations: (1) a proliferative, predominantly basilar, arachnoiditis; (2) vasculitis of the arteries and veins traversing this exudate; and (3) disturbance of cerebrospinal fluid (CSF) circulation or resorption leading to hydrocephalus.

Proliferative arachnoiditis is most marked at the base of the brain and, in a matter of days or weeks, produces a thick, gelatinous exudate extending from the pons to the optic chiasm. With chronicity, the optochiasmic zone of arachnoiditis comes to resemble a fibrous mass encasing nearby cranial nerves and blood vessels.

Vasculitis with resultant thrombosis and hemorrhagic infarction develops in vessels that traverse the basilar or spinal exudate or those that are located within the brain substance itself. The vascular inflammatory reaction is initiated by direct invasion of the adventitia by mycobacteria or by secondary extension of adjacent arachnoiditis. An early polymorphonuclear reaction followed by infiltration of lymphocytes, plasma cells, and macrophages leads to progressive destruction of the adventitia, disruption of elastic fibers, and extension of the inflammatory process to the intima. Eventually, fibrinoid degeneration in small arteries and veins produces aneurysms, multiple thrombi, and focal hemorrhage in some combination. Depending on the location and extent of the vasculitis, a variety of stroke syndromes may result. Multiple lesions are common, and areas of ischemic injury that simulate lacunar infarctions most frequently involve the basal ganglia, cerebral cortex, pons, and cerebellum. Intracranial vasculitis and multiple infarcts are a common feature of autopsy studies and account for much of the residual neurologic disabilities observed in patients who survive.

Extension of the inflammatory process to the basilar cisterns impedes CSF circulation and resorption, leading to communicating hydrocephalus in most cases that have been symptomatic for longer than 2 to 3 weeks. Obstruction of the aqueduct develops less frequently from contraction of exudate surrounding the brainstem or from a strategically placed brainstem tuberculoma. In far-advanced cases, increased intracranial pressure may lead to brainstem compression and tentorial herniation.

Clinical Presentation

Symptoms and Signs

Typically, tuberculous meningitis begins with a prodrome of insidious onset characterized by malaise, lassitude, personality change, intermittent headache, and low-grade fever. This is followed, usually within 2 to 3 weeks, by more prominent neurologic symptoms and signs such as meningismus, protracted headache, vomiting, confusion, cranial nerve palsies, and long-tract signs. The pace of illness may accelerate rapidly at this stage; confusion gives way to stupor and coma, seizures may occur, and multiple cranial nerve palsies and hemiparesis or hemiplegia are common. In most untreated cases, death supervenes within 5 to 8 weeks of the onset of illness although in occasional patients the illness follows a more indolent, slowly progressive course over weeks or months. In children, the condition is characterized early by irritability, loss of interest in play, restlessness, and anorexia; headache is less common and vomiting often much more prominent, especially in the very young. Seizures are more common in children and are likely to be an early or presenting symptom. Table 40-1 lists common symptoms and signs at presentation.

Table 40-1
Presenting Symptoms and Signs of Tuberculous Meningitis
Symptoms/Signs Frequency (%)
Fever 60–90
Headache 40–90
Vomiting 30–60
Neck stiffness 40–80
Lethargy/drowsiness 25–80
Confusion 10–30
Stupor/coma 5–30
Focal neurologic signs 15–40
Cranial nerve palsy 20–40
Hemiparesis 10–20
Seizures
Children 40–50
Adults 5

For purposes of prognosis and treatment, it is useful to categorize disease severity on presentation in reference to mental status and focal neurologic signs. Stage I comprises patients who have normal mental state, with or without meningismus but with no focal neurologic signs or evidence of hydrocephalus; stage II patients exhibit lethargy and confusion and may have mild focal neurologic signs such as single cranial nerve palsies and hemiparesis; stage III includes signs of advanced disease such as stupor and coma, seizures, multiple cranial nerve palsies, dense hemiplegia, and paraplegia. Some patients progress rapidly from one stage to the next within a few days of observation. The response to treatment is influenced significantly by the stage of disease at the time therapy is initiated, with better outcomes achieved when treatment is started early before the illness progresses from one clinical stage to the next.

Atypical Features

Adult patients may also present with a slowly progressive dementia over many months, characterized by personality change, social withdrawal, and memory deficits. At the other end of the spectrum are patients who present with an acute, rapidly progressive meningitic syndrome indistinguishable from pyogenic bacterial meningitis; at times, this accelerated form is superimposed on a chronic dementing illness. Seizures and focal neurologic disturbances such as cranial nerve palsies or hemiparesis may occur early and dominate the clinical presentation. Of the cranial nerves, the sixth is the most commonly involved, followed by the third and fourth. Occasionally the symptoms and signs of hydrocephalus with raised intracranial pressure (e.g., headache, papilledema, diplopia, and visual disturbance) precede signs of meningeal inflammation. Movement disorders, including tremor, myoclonus, chorea, and ballismus, may follow basal ganglia infarction secondary to vasculitis.

Tuberculous Meningitis and HIV Infection

CNS manifestations of tuberculosis are encountered with greater frequency in persons with tuberculosis who are coinfected with HIV. In a study of 455 HIV-positive patients with tuberculosis, 10 percent developed meningitis compared with 2 percent of HIV-negative patients, and HIV-positive patients accounted for 59 percent of all cases of tuberculous meningitis seen during the study period. In comparison to non-HIV infected patients with tuberculous meningitis, coinfection with HIV has little impact on presenting clinical features, laboratory findings, or early response to therapy, though intracerebral tuberculomas are observed more commonly on neuroimaging studies in this population.

The initiation of antiretroviral therapy (ART) in treatment-naïve individuals coinfected with HIV and tuberculosis may lead to complications from the immune reconstitution inflammatory syndrome (IRIS) that follows restoration of immune responsiveness. Tuberculosis IRIS presents with signs of rapidly progressive extrapulmonary infection (e.g., fever, lymphadenopathy, respiratory symptoms, and meningitis) or clinical deterioration in patients previously improving on antituberculous therapy. In a series of 279 patients with tuberculosis-associated IRIS, progression to CNS tuberculosis developed in 12 percent, and excess mortality attributable to IRIS was observed in 30 percent of patients. Manifestations of progressive CNS disease associated with IRIS include meningitis, brain abscess/tuberculoma, and rediculomyelitis.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here